XML 58 R45.htm IDEA: XBRL DOCUMENT v3.3.1.900
Notes Payable - Additional Information (Detail)
1 Months Ended 12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
shares
Nov. 26, 2015
USD ($)
Oct. 26, 2015
USD ($)
Aug. 20, 2014
USD ($)
Borrowing
Oct. 31, 2015
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
Jul. 01, 2015
USD ($)
Apr. 06, 2015
USD ($)
Jan. 06, 2015
USD ($)
Nov. 04, 2014
USD ($)
Oct. 17, 2012
USD ($)
Jun. 08, 2010
USD ($)
May. 16, 2006
$ / shares
Sep. 26, 2005
USD ($)
Class of Warrant or Right [Line Items]                              
Maximum borrowing capacity       $ 20,000,000                      
Number of borrowings | Borrowing       5                      
Minimum cash balance $ 10,000,000         $ 10,000,000                  
Minimum cash balance under certain circumstances 15,000,000         15,000,000                  
Cash balance 12,600,000         12,600,000                  
Royalties payable under the Royalty Agreement $ 208,000         $ 208,000                  
Loan maturity description           Loan will mature on the earlier of (a) December 31, 2019, and, (b) 30 days after the end of any fiscal year in which the Company's cash (plus certain cash expenditures during such fiscal year that are unrelated to the B12 Product or related products) as of the end of such fiscal year (subject to certain permitted deductions) is more than three times the principal amount of the Loan as of the end of such fiscal year.                  
Interest rate 13.00%         13.00%                  
Debt instrument interest rate terms           Interest at a rate of 13% per annum (the "Interest Rate"), compounded monthly, and will be payable in kind and in arrears on June 30 and December 31 of each year                  
Cash sweep as percentage of Consolidated Free Cash Flow           75.00%                  
Cash sweep as percentage of Consolidated Free Cash Flow upon conditions           75.00%                  
Cash sweep value           $ 50,000,000                  
Cash sweep as percentage of cash proceeds           50.00%                  
Payment received from Novo Nordisk     $ 14,000,000   $ 14,000,000                    
Debt instrument, description           On August 20, 2014, the Lenders and the Company further amended and restated (i) the Convertible Notes issued by the Company to certain of the Lenders, (ii) the Bridge Notes issued by the Company to certain of the Lenders, and (iii) the Reimbursement Notes (and, together with the Convertible Notes and Bridge Notes, the "MHR Notes").                  
Net proceeds of secured loan agreement                             $ 12,900,000
Conversion price per share | $ / shares                           $ 3.78  
11% Senior secured convertible notes loan agreement, execution date           May 16, 2006                  
Restructuring initiation date           Aug. 20, 2014                  
Minimum percentage of common stock outstanding to provide continuity to Mutual Nominee on Board           2.00%                  
Convertible Notes [Member]                              
Class of Warrant or Right [Line Items]                              
Principal amount $ 46,500,000         $ 46,500,000                  
Interest rate 13.00%         13.00%                  
Cash sweep as percentage of Consolidated Free Cash Flow           50.00%                  
Cash sweep value           $ 50,000,000                  
Cash sweep as percentage of cash proceeds           50.00%                  
Conversion price per share | $ / shares $ 1.25         $ 1.25                  
Maturity date           Mar. 31, 2022                  
Shares of common stock | shares           37,233,561                  
Royalty Agreement [Member]                              
Class of Warrant or Right [Line Items]                              
Royalty agreement date           Aug. 20, 2014                  
Net sales percentage on royalty agreement 20.00%         20.00%                  
Net sales percentage on royalty agreement 5.00%         5.00%                  
Net sales percentage on royalty agreement 2.50%         2.50%                  
Royalty agreement description           (i) five percent (5%) of all Net Sales and third party payments commencing with the first quarter immediately following the quarter in which the Indebtedness Repayment Condition is satisfied, or (ii) two and one half percent (2.5%) of all Net Sales commencing with the quarter immediately following the quarter in which the Indebtedness Repayment Condition is satisfied, but only with respect to the Net Sales made in any country in which there was not a Valid Patent Claim (as defined in the Royalty Agreement) and where generic entry of a competitive product not by the Company or its affiliates that does not infringe a Valid Patent Claim in such country has occurred, in each case as of the last day of such Fiscal Quarter.                  
Maximum [Member]                              
Class of Warrant or Right [Line Items]                              
Additional borrowings capacity               $ 2,000,000              
Period on certain loans and notes           1 year                  
MHR Promissory Notes [Member]                              
Class of Warrant or Right [Line Items]                              
Principal amount                         $ 600,000   $ 15,000,000
Interest rate                             11.00%
Additional interest rate as an event of default           2.00%                  
Restructuring initiation date           May 07, 2013                  
MHR Promissory Notes [Member] | Royalty Agreement [Member]                              
Class of Warrant or Right [Line Items]                              
Professional fees             $ 225,000                
Loan Agreement [Member]                              
Class of Warrant or Right [Line Items]                              
Maximum borrowing capacity $ 20,000,000         $ 20,000,000                  
Principal amount 22,800,000     $ 5,000,000   $ 22,800,000   $ 2,000,000 $ 5,000,000 $ 5,000,000 $ 3,000,000        
Cash sweep as percentage of Consolidated Free Cash Flow           50.00%                  
Maturity date           Dec. 31, 2019                  
Reimbursement Notes [Member]                              
Class of Warrant or Right [Line Items]                              
Principal amount $ 800,000         $ 800,000                  
Interest rate 10.00%         10.00%                  
Debt instrument interest rate terms           Interest at the rate of 10% per annum, compounded monthly, which interest is payable in the form of additional Reimbursement Notes.                  
Cash sweep as percentage of Consolidated Free Cash Flow           50.00%                  
Prepayment of notes and loans   $ 800,000                          
Notes and loans payable $ 800,000         $ 800,000                  
Conversion price per share | $ / shares $ 0.50         $ 0.50                  
Restructuring initiation date           Aug. 20, 2014                  
Maturity date           Mar. 31, 2022                  
Shares of common stock | shares 1,510,682                            
Bridge Notes [Member]                              
Class of Warrant or Right [Line Items]                              
Principal amount $ 2,100,000         $ 2,100,000           $ 1,400,000      
Interest rate 13.00%         13.00%                  
Debt instrument interest rate terms           Interest at 13% per year, compounded monthly and payable in the form of additional Bridge Notes.                  
Cash sweep as percentage of Consolidated Free Cash Flow           50.00%                  
Maturity date           Mar. 31, 2022                  
Shares of common stock | shares 4,229,826                            
Convertible Notes default description           The Bridge Notes were amended and restated on May 7, 2013 and restated again on August 20, 2014.                  
Debt instrument convertible amended conversion price | $ / shares           $ 0.50                  
Loans Payable [Member]                              
Class of Warrant or Right [Line Items]                              
Prepayment of notes and loans   $ 6,200,000                          
Notes and loans payable $ 6,200,000         $ 6,200,000